AMED iD3 Catalyst Unit is in charge of public relations activities of Innovative Drug Discovery and Development (iD3) Booster that AMED advances. 

The iD3 Booster is unique, unprecedented approach by Japan Medical Research and Development (AMED) for accelerating the translation of promising basic researches in academia into innovative new medicines. The iD3 Booster provides integrated support on strategy, technology, and funding to accelerate the translation of unique and promising research in academia. If you have promising drug seeds, pleasse contact the iD3 Navi. Experience drug discovery experts will provide free consultaions.  

PV: Bridging unique basic research results with practical application

  Symposiums and lectures
Catalyst Unit hold symposiums and provide lectures on a regular basis. At "Translational and Regulatory Sciences Symposium," which is held once a year, we invite experts in various fields from industry, government, and academia, and aming for collaboration and promotion of translational science and regulatory science. At "Top Runners in TRS," which held a few times a year, a top expert is invited and provide lectures.  

The 3rd top runners in TRS
On July 30, Catalyst Unit will held the 3rd Top Runners in TRS. Please register through Catalyst Unit Website.

Theme:     Development and application of animal behavior analysis system using images
Lecturer:   Takahisa Murata, Associate Professor,
                  Department of Animal Radiology, Graduate School of Agricultra and Life
                  Science, The University of Tokyo
Date:          July 30, Friday     16:00 - 17:30
Place:         On line (Zoom) 
Application: https://id3catalyst.jp/20210730/

* Free of charge but prior registration is necessary. 

Catalyst Unit website
Through website, Catalyst Unit provides various infrmation including introduction of iD3 units, interview to scientists who command attention, colums by experts in various fields, event information. Please visit our website for more details.
  International online journal, Translational and Regulatory Sciences (TRS) was first published in Augut 2019. TRS inludes original articles, presentation contents at symposiums and lectures, outcomes of projects supported by AMED, and so on.  Vol. 3-2 is the newest issue (7th in total) as of July 2021. TRS charges no access fee, no author fee, and no publication fees. Please visit TRS website.